Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: Results from the ATLAS trial

Archives of Internal Medicine

Volumn 161, Issue 2, 2001, Pages 165-171

  Massie, Barry M ^a,h   Armstrong, Paul W ^b   Cleland, John G F ^c   Horowitz, John D ^d   Packer, Milton ^e   Poole Wilson, Philip A ^f   Rydén, Lars ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF HULL   (United Kingdom)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e Columbia University ^*  (United States)

^f IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^g KAROLINSKA INSTITUTE   (Sweden)

^h SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; HYPERKALEMIA; HYPOTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TITRIMETRY;

EID: 0035931330     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.2.165     Document Type: Article

References (22)

1. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
2. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
3. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
4. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
5. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction
6. Effects of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
7. Guidelines for the evaluation and management of heart failure
8. The treatment of heart failure
9. Consensus recommendations for the management of chronic heart failure
10. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure
11. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states
12. Differences between primary care physicians and cardiologists in management of congestive heart failure: Relation to practice guidelines
13. Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989-1995
14. Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting
15. Patterns of angiotensin-converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure
16. ACE inhibitors for heart failure: A question of dose
17. Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice?
18. Determinants of mortality in elderly patients with heart failure: The role of angiotensin-converting enzyme inhibitors
19. Comparative effects of low doses and high doses of the angiotensin converting-enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure
20. Regional differences in the characteristics and treatment of patients participating in an international heart failure trial
21. A placebo-controlled trial of captopril in refractory chronic congestive heart failure